DK0464727T3 - Anvendelse af en sammensætning til fremstilling af et medikament for debridment af tilbageholdte linsematerialer - Google Patents

Anvendelse af en sammensætning til fremstilling af et medikament for debridment af tilbageholdte linsematerialer

Info

Publication number
DK0464727T3
DK0464727T3 DK91110799.3T DK91110799T DK0464727T3 DK 0464727 T3 DK0464727 T3 DK 0464727T3 DK 91110799 T DK91110799 T DK 91110799T DK 0464727 T3 DK0464727 T3 DK 0464727T3
Authority
DK
Denmark
Prior art keywords
debridement
drug
manufacture
composition
lens materials
Prior art date
Application number
DK91110799.3T
Other languages
Danish (da)
English (en)
Inventor
Okihiro Nishi
Kayo Nishi
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0464727T3 publication Critical patent/DK0464727T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91110799.3T 1990-06-29 1991-06-28 Anvendelse af en sammensætning til fremstilling af et medikament for debridment af tilbageholdte linsematerialer DK0464727T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17291490 1990-06-29

Publications (1)

Publication Number Publication Date
DK0464727T3 true DK0464727T3 (da) 1996-02-05

Family

ID=15950689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91110799.3T DK0464727T3 (da) 1990-06-29 1991-06-28 Anvendelse af en sammensætning til fremstilling af et medikament for debridment af tilbageholdte linsematerialer

Country Status (5)

Country Link
US (1) US5204331A (de)
EP (1) EP0464727B1 (de)
JP (1) JPH07116030B2 (de)
DE (1) DE69116010T2 (de)
DK (1) DK0464727T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4225489A1 (de) * 1992-07-30 1994-02-03 Michael Prof Dr Rer Na Dittgen Verfahren zur Herstellung bioadhäsiver Augentropfen
US5292525A (en) * 1992-10-14 1994-03-08 Merck & Co., Inc. Method and composition for removing an alginate from a cutaneous substrate
WO1995034302A2 (en) * 1994-06-16 1995-12-21 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
US5620013A (en) * 1994-10-21 1997-04-15 American Cyanamid Company Method for destroying residual lens epithelial cells
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US6350780B1 (en) 1995-07-28 2002-02-26 Allergan Sales, Inc. Methods and compositions for drug delivery
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
AU3624299A (en) * 1998-02-04 1999-08-23 Kiyoshi Okada Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification
US6186148B1 (en) 1998-02-04 2001-02-13 Kiyoshi Okada Prevention of posterior capsular opacification
US6533769B2 (en) * 2001-05-03 2003-03-18 Holmen Joergen Method for use in cataract surgery
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
JP4074533B2 (ja) * 2003-03-06 2008-04-09 セイコーエプソン株式会社 電気光学装置及び電子機器
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
DE102004021754A1 (de) 2004-04-30 2005-11-24 Reinhardt Thyzel Vorrichtung zum Entfernen von Epithelzellen aus einem Linsenkapselsack eines menschlichen oder tierischen Auges
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
US20080141628A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Packaging Solutions
US9579341B2 (en) 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US8609634B2 (en) 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US9095558B2 (en) 2010-10-08 2015-08-04 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
CN104981259B (zh) * 2012-12-11 2017-03-08 得克萨斯系统大学评议会 包含防粘连的水凝胶膜的试剂盒
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
DE102013017948B4 (de) * 2013-10-29 2018-10-11 Carl Zeiss Meditec Ag Flüssigkeiten und Gels für die Ophthalmologie und Mikroskopiesystem zur Beobachtung der selben
JP6950524B2 (ja) * 2017-12-28 2021-10-13 トヨタ自動車株式会社 ハイブリッド車両の制御装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328803B1 (en) * 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
US4486416A (en) * 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma
EP0244178A3 (de) * 1986-04-28 1989-02-08 Iolab, Inc Intraokuläre Mittel und Verfahren zu deren Verwendung
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
JPH075456B2 (ja) * 1988-10-01 1995-01-25 参天製薬株式会社 点眼液

Also Published As

Publication number Publication date
JPH07116030B2 (ja) 1995-12-13
EP0464727A3 (en) 1992-09-30
EP0464727B1 (de) 1996-01-03
DE69116010D1 (de) 1996-02-15
JPH04352719A (ja) 1992-12-07
EP0464727A2 (de) 1992-01-08
DE69116010T2 (de) 1996-05-30
US5204331A (en) 1993-04-20

Similar Documents

Publication Publication Date Title
DK0464727T3 (da) Anvendelse af en sammensætning til fremstilling af et medikament for debridment af tilbageholdte linsematerialer
DE69215600D1 (de) Mehr-Komponenten Intraokularlinse
DE69227407D1 (de) Superlumineszierende optische Quelle
FR2645282B1 (fr) Barillet d'objectif zoom
DE69125328D1 (de) Feldkompensierte Linse
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
DE69219248D1 (de) Zoomobjektiv
DE69116273D1 (de) Linsentubus
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
KR910001223U (ko) 줌 렌즈 카메라
KR910003103U (ko) 싱글렌즈 리플렉스 카메라
KR910001222U (ko) 줌 렌즈 카메라
DK0485069T3 (da) Fremgangsmåde til fremstilling af optisk aktive aminer
UA26064A1 (uk) Фармацевтичhа композиція
IT9020144A0 (it) Composizione farmaceutica contenente egf
DE69133517D1 (de) Progressive linse
MX9100164A (es) Pirazolidinonas substituidas,biologicamente activas,que se unen a los receptores de la colecistoquinina y composiciones farmaceuticas que las contienen
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DE69024838D1 (de) Linsentubus
DK527288A (da) Fremgangsmaade til fremstilling af et kompositmateriale
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
NO306381B1 (no) Farmasöytisk ampulle
DE69118261D1 (de) Optisch aktive Delta-Valerolacton-Ring enthaltende Verbindung und dieselbe enthaltende flüssigkristalline Zusammensetzung
DK188689D0 (da) Linse
DK2388A (da) Fremstilling af polyethermaterialer